Article

Structural and Phenotypic Correction of K210del Genetic Cardiomyopathy by an FDA Approved Drug

2023-01-12

Abstract excerpt

<title>Abstract</title> <p>Dilated cardiomyopathy (DCM), which results from genetic disorders resulting in decreased myocardial contractility, is a leading cause of morbidity and mortality worldwide. There are several therapeutic challenges in treating DCM, which include poor understanding of the underlying mechanism of impaired myocardial contractility, and the difficulty of developing targeted therapies to reve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a9a156d8-302d-5095-bbc3-267d5b413e58
DOI: 10.21203/rs.3.rs-2331399/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Structural and Phenotypic Correction of K210del Genetic Cardiomyopathy by an FDA Approved DrugDOI 10.21203/rs.3.rs-2331399/v1Read

Harnessing molecular mechanism for precision medicine in dilated cardiomyopathy caused by a mutation in troponin TSemantic proximity Read

Disrupted Mechanobiology Links the Molecular and Cellular Phenotypes in Familial Dilated CardiomyopathySemantic proximity Read

Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathySemantic proximity Read

Genotype-specific pathogenic effects in human dilated cardiomyopathy.Semantic proximity Read

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy.Semantic proximity Read

Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy.Semantic proximity Read

RBM20-variants induce distinct calcium handling and metabolic phenotypes in patient-specific stem cell models of dilated and non-compaction cardiomyopathySemantic proximity Read

Establishing disease causality for a novel gene variant in familial dilated cardiomyopathy using a functional in-vitro assay of regulated thin filaments and human cardiac myosin.Semantic proximity Read

Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling.Semantic proximity Read

Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.Semantic proximity Read

Variant R94C in TNNT2-Encoded Troponin T Predisposes to Pediatric Restrictive Cardiomyopathy and Sudden Death Through Impaired Thin Filament Relaxation Resulting in Myocardial Diastolic Dysfunction.Semantic proximity Read

An in silico analysis of troponin I mutations in hypertrophic cardiomyopathy of Indian origin.Semantic proximity Read